SIGA Technologies Says Japan's Pharmaceutical Regulator Approves Its Antiviral Treatment for Smallpox, MPox, Cowpox
SIGA Technologies Says Japan's Pharmaceutical Regulator Approves Its Antiviral Treatment for Smallpox, MPox, Cowpox
SIGA Technologies表示,日本的药品监管机构批准了其针对天花、猴痘和牛痘的抗病毒治疗方案。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册